Editas Medicine Inc (EDIT) — Long-term Investment Intensity
Editas Medicine Inc (EDIT) has a Long-term Investment Intensity of 10.2% as of June 2024. Long-term investments of $39.20 Million represent 10.2% of total assets of $384.80 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Editas Medicine Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Editas Medicine Inc Long-term Investment Intensity (2018–2023)
This chart shows how Editas Medicine Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the intensity stands at 10.2%, reflecting long-term investments of $39.20 Million against total assets of $384.80 Million USD. Explore Editas Medicine Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Editas Medicine Inc (2018–2023)
The table below presents the year-by-year Long-term Investment Intensity for Editas Medicine Inc from 2018 to 2023, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Editas Medicine Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 20.8% | $104.02 Million | $499.15 Million | ▲ +2.7 pp |
| 2022 | 18.1% | $93.10 Million | $514.32 Million | ▲ +0.4 pp |
| 2021 | 17.7% | $120.07 Million | $677.48 Million | ▼ -1.4 pp |
| 2020 | 19.2% | $109.66 Million | $572.60 Million | ▲ +18.4 pp |
| 2019 | 0.7% | $3.67 Million | $508.88 Million | ▼ -0.2 pp |
| 2018 | 0.9% | $3.67 Million | $420.39 Million | — |